Sirolimus-Eluting Iron Bioresorbable Scaffolds Versus Everolimus-Eluting Stents in Patients with Coronary Artery Disease: A Single-Blind, Randomised Trial (IRONMAN II)

Runlin Gao, Lei Song, Guosheng Fu, Changdong Guan, Yang Li, Shaobin Jia, Yong‐Ming He, Ji-yan Chen, Feng Qi, Mengyue Yu, Bo Yang, Yaojun Zhang, Zheng Zhang, Shenghu He, Yundai Chen, Yitong Ma, Yujie Zhou, Le Wang, Guowei Zhao, Juying Qian, Ning Guo, Zhongwei Sun, Yunfei Huang, Wei Li, Junbo Ge, Yaling Han, Gregg W. StoneSSRN 2025 · DOI

BibTeX
@misc{gao2025sirolimus,
  author = {Runlin Gao and Lei Song and Guosheng Fu and Changdong Guan and Yang Li and Shaobin Jia and Yong‐Ming He and Ji-yan Chen and Feng Qi and Mengyue Yu and Bo Yang and Yaojun Zhang and Zheng Zhang and Shenghu He and Yundai Chen and Yitong Ma and Yujie Zhou and Le Wang and Guowei Zhao and Juying Qian and Ning Guo and Zhongwei Sun and Yunfei Huang and Wei Li and Junbo Ge and Yaling Han and Gregg W. Stone},
  title = {{Sirolimus-Eluting Iron Bioresorbable Scaffolds Versus Everolimus-Eluting Stents in Patients with Coronary Artery Disease: A Single-Blind, Randomised Trial (IRONMAN II)}},
  year = {2025},
  doi = {10.2139/ssrn.5487804},
  howpublished = {SSRN},
}

Loading related content...

Figure